Regulation of keratinocyte signaling and function via changes in epidermal growth factor presentation.
Motivated by the need for bioactive materials that can accelerate dermal wound healing, this work describes the responses of keratinocytes to covalently immobilized epidermal growth factor (EGF) and how differences in the physical presentation of this growth factor affect cell function. Specifically, human keratinocytes were cultured with EGF delivered in soluble form, immobilized in a homogeneous pattern or immobilized in a gradient pattern, followed by analysis of cellular signaling, proliferation and migration. By changing the manner in which EGF was presented, keratinocyte behavior was dramatically altered. Keratinocytes responded to immobilized EGF patterns with high EGF receptor (EGFR) but low ERK1/2 and Akt phosphorylation, accompanied by low proliferation, high migratory activity and coordinated cell alignment. In contrast, keratinocytes treated with soluble EGF experienced lower EGFR but higher ERK1/2 and Akt phosphorylation and displayed a highly proliferative, rather than migratory, phenotype. Keratinocytes also responded to differences in immobilized EGF patterns, as migration was fastest upon immobilized gradients of EGF. A better understanding the interaction of cells with soluble vs. immobilized growth factors can help elucidate native healing events and achieve greater control over cell function, which may be useful in the development of wound repair treatments for many types of tissues.
Puccinelli
Tracy J
TJ
Materials Science Program, University of Wisconsin, Madison, WI 53706, USA.
Bertics
Paul J
PJ
Masters
Kristyn S
KS
D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D004815:Epidermal Growth Factor / Q000378:metabolism / Q000494:pharmacology*; D066246:ErbB Receptors / Q000378:metabolism; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D006801:Humans; D055767:Immobilized Proteins / Q000378:metabolism / Q000494:pharmacology*; D015603:Keratinocytes / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D008027:Light; D010766:Phosphorylation / Q000187:drug effects; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D012995:Solubility / Q000187:drug effects
D055767:Immobilized Proteins; D004815:Epidermal Growth Factor; D066246:ErbB Receptors; D051057:Proto-Oncogene Proteins c-akt; D048049:Extracellular Signal-Regulated MAP Kinases
Biomaterials. 1999 Dec;20(23-24):2333-42
10614939
J Cell Physiol. 2009 Nov;221(2):306-17
19544388
Biomaterials. 2006 Jun;27(16):3044-63
16458351
J Cell Sci. 2008 Mar 1;121(Pt 5):551-9
18287584
Drugs Today (Barc). 2003 Oct;39(10):787-800
14668934
J Biol Chem. 2004 Aug 27;279(35):36972-81
15215236
Stem Cells. 2009 Nov;27(11):2804-14
19750537
Arch Dermatol Res. 2009 Apr;301(4):307-17
19330341
Ann Biomed Eng. 2008 Dec;36(12):2121-33
18850272
Exp Cell Res. 2008 Nov 1;314(18):3415-25
18817771
J Gastroenterol. 1998 Apr;33(2):295-302
9605966
Biomaterials. 2008 Dec;29(35):4676-83
18801569
Biochim Biophys Acta. 1997 Sep 11;1358(2):200-8
9332456
Bioconjug Chem. 1998 Mar-Apr;9(2):277-82
9548545
Dermatol Clin. 2007 Oct;25(4):477-85, vii
17903607
Int J Biochem Cell Biol. 1999 Jun;31(6):637-43
10404636
J Biomed Mater Res A. 2004 Feb 1;68(2):235-43
14704965
Acta Biomater. 2008 Jul;4(4):1016-23
18359670
Biomaterials. 2001 Mar;22(5):439-44
11214754
Biomaterials. 2009 Sep;30(27):4618-28
19540581
Macromol Biosci. 2006 Oct 20;6(10):827-38
17039575
J Biomater Sci Polym Ed. 2003;14(4):383-94
12747676
Biochem J. 1999 May 1;339 ( Pt 3):481-8
10215583
Acta Biomater. 2008 May;4(3):477-89
18328795
Annu Rev Biomed Eng. 2001;3:335-73
11447067
Circ Res. 2004 Mar 5;94(4):550-8
14739157
Biomaterials. 1997 Sep;18(18):1201-25
9300556
Int J Cancer. 1992 Sep 30;52(3):461-70
1328069
J Biochem. 1997 Mar;121(3):514-20
9133620
Matrix Biol. 2005 Sep;24(6):428-37
16055320
Am J Physiol Gastrointest Liver Physiol. 2004 Dec;287(6):G1227-37
15284024
Eur J Dermatol. 2000 Oct-Nov;10(7):505-10
11056418
J Biomed Mater Res. 2002 Apr;60(1):86-93
11835163
Science. 1997 Apr 4;276(5309):75-81
9082989
Wound Repair Regen. 2007 Nov-Dec;15(6):847-55
18028133
Bioessays. 2000 Aug;22(8):697-707
10918300
J Biomech. 2007;40(5):1011-23
16793050
Biomaterials. 2008 May;29(15):2388-99
18313747
Health Technol Assess. 2000;4(21):1-237
11074391
Anal Sci. 2008 Jan;24(1):67-72
18187851
BMC Health Serv Res. 2009 Jul 10;9:115
19591680
Stem Cells. 2007 May;25(5):1241-51
17234993
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2292-6
3470794
EMBO Rep. 2006 Aug;7(8):782-6
16880823
J Invest Dermatol. 2008 Jun;128(6):1365-74
18049451
J Biochem. 2001 May;129(5):733-7
11328595